Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Regency Centers | REG | Nov 26, 2024 | 75.00 | +1.32 |
Regency Centers A Pref | REGCP | Nov 26, 2024 | 24.08 | -1.11 |
Regency Centers B Pref | REGCO | Nov 26, 2024 | 22.72 | -2.28 |
Regeneron Pharmaceuticals | REGN | Nov 26, 2024 | 753.03 | +0.47 |
REGENXBIO | RGNX | Nov 26, 2024 | 9.55 | -0.31 |
Regional Health Properties | RHE | Nov 26, 2024 | 1.61 | +0.01 |
Regional Health Properties A Pref | RHE-A | Nov 26, 2024 | 0.55 | +21.09 |
Regional Management | RM | Nov 26, 2024 | 30.72 | -0.68 |
Regions Financial | RF | Nov 26, 2024 | 27.31 | -0.58 |
Regions Financial B Pref | RF-B | Nov 26, 2024 | 24.98 | 0.00 |
Regions Financial C Pref | RF-C | Nov 26, 2024 | 24.64 | -0.81 |
Regions Financial E Pref | RF-E | Nov 26, 2024 | 19.39 | -1.02 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Nov 26, 2024 | 25.95 | -0.23 |
Regis | RGS | Nov 26, 2024 | 23.05 | +8.47 |
Regulus Therapeutics | RGLS | Nov 26, 2024 | 1.53 | +0.66 |
Reinsurance Group of America | RGA | Nov 26, 2024 | 231.64 | +0.09 |
REIT Index ETF Vanguard | VNQ | Nov 26, 2024 | 97.97 | +0.40 |
Reitar Logtech | RITR | Nov 26, 2024 | 4.08 | 0.00 |
Rekor Systems | REKR | Nov 26, 2024 | 1.01 | +5.77 |
Relay Therapeutics | RLAY | Nov 26, 2024 | 4.76 | -2.06 |
Reliance | RS | Nov 26, 2024 | 321.91 | -0.36 |
Reliance Global | RELI | Nov 26, 2024 | 1.43 | -10.63 |
Relmada Therapeutics | RLMD | Nov 26, 2024 | 2.72 | -1.45 |
RELX ADR | RELX | Nov 26, 2024 | 46.81 | +0.52 |
Remitly Global | RELY | Nov 26, 2024 | 20.81 | +1.41 |
Renaissance Ipo ETF | IPO | Nov 26, 2024 | 46.64 | -0.77 |
RenaissanceRe | RNR | Nov 26, 2024 | 282.38 | +0.97 |
RenaissanceRe G Pref | RNR-G | Nov 26, 2024 | 18.05 | -0.99 |
RenaissanceRe Holding F Pref | RNR-F | Nov 26, 2024 | 24.50 | -0.33 |
Renalytix ADR | RNLX | Nov 26, 2024 | 0.20 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.